After advancing more than 50 per cent in the past six months, shares in medical imaging software business Pro Medicus have reversed direction following its first-half profit miss.
The $10 billion company used the 20 per cent plunge in its valuation as an opportunity to buy back about $2.8 million in stock last week.
Loading...
Tess Bennett is a technology reporter with The Australian Financial Review, based in the Brisbane newsroom. She was previously the work & careers reporter. Connect with Tess on Twitter. Email Tess at tess.bennett@afr.com
